Dr. Wylie Hosmer, MD
Claim this profileHartford Hospital
Studies Non-Small Cell Lung Cancer
Studies Lung Cancer
6 reported clinical trials
26 drugs studied
Area of expertise
1Non-Small Cell Lung Cancer
Stage II
Stage I
Stage III
2Lung Cancer
Stage II
Stage I
Stage III
Affiliated Hospitals
Clinical Trials Wylie Hosmer, MD is currently running
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about Wylie Hosmer, MD
Clinical Trial Related9 years of experience running clinical trials · Led 6 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Wylie Hosmer, MD has experience with
- Crizotinib
- Pembrolizumab
- Futibatinib
- Sunitinib
- Regorafenib
- Temsirolimus
Breakdown of trials Wylie Hosmer, MD has run
Non-Small Cell Lung Cancer
Lung Cancer
Colorectal Cancer
Multiple Myeloma
Non-Hodgkin's Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Wylie Hosmer, MD specialize in?
Wylie Hosmer, MD focuses on Non-Small Cell Lung Cancer and Lung Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage II patients, or patients who are Stage I.
Is Wylie Hosmer, MD currently recruiting for clinical trials?
Yes, Wylie Hosmer, MD is currently recruiting for 6 clinical trials in Hartford Connecticut. If you're interested in participating, you should apply.
Are there any treatments that Wylie Hosmer, MD has studied deeply?
Yes, Wylie Hosmer, MD has studied treatments such as Crizotinib, Pembrolizumab, Futibatinib.
What is the best way to schedule an appointment with Wylie Hosmer, MD?
Apply for one of the trials that Wylie Hosmer, MD is conducting.
What is the office address of Wylie Hosmer, MD?
The office of Wylie Hosmer, MD is located at: Hartford Hospital, Hartford, Connecticut 06102 United States. This is the address for their practice at the Hartford Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.